Back to User profile » Dr Takashi Seto

Papers published by Dr Takashi Seto:


Anti–PD-1 Monotherapy for Advanced NSCLC Patients with Older Age or Those with Poor Performance Status

Matsubara T, Seto T, Takamori S, Fujishita T, Toyozawa R, Ito K, Yamaguchi M, Okamoto T

OncoTargets and Therapy 2021, 14:1961-1968

Published Date: 17 March 2021

Rapidly Destructive Coxarthrosis as a Potential Side Effect of Crizotinib in a Patient with ROS1-Positive Lung Adenocarcinoma

Takamori S, Seto T, Jinnouchi M, Oba T, Yamaguchi M, Takenoyama M

Therapeutics and Clinical Risk Management 2020, 16:17-20

Published Date: 17 January 2020

Spotlight on lorlatinib and its potential in the treatment of NSCLC: the evidence to date

Akamine T, Toyokawa G, Tagawa T, Seto T

OncoTargets and Therapy 2018, 11:5093-5101

Published Date: 22 August 2018